Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma

Author:

Huang Dachuan12,Lim Jing Quan12ORCID,Cheah Daryl Ming Zhe1,Kahliab Khalilatul Hanisah Binte Mohd1ORCID,Laurensia Yurike1,Pang Jane Wan Lu1,Wong Esther Kam Yin1,Chia Burton Kuan Hui1,Goh Jasmine3,Zhang Xiyun3,Chan Jason Yongsheng4ORCID,Chow Edward Kai-Hua3,Tan Soo Yong5ORCID,Lim Soon Thye246ORCID,Ong Choon Kiat127ORCID

Affiliation:

1. Lymphoma Genomic Translational Research Laboratory, Division of Medical Oncology, National Cancer Centre, Singapore;

2. Duke-NUS Medical School, Singapore;

3. Cancer Science Institute of Singapore, National University of Singapore, Singapore;

4. Division of Medical Oncology, National Cancer Centre Singapore, Singapore;

5. National University of Singapore Yong Loo Lin School of Medicine, Singapore;

6. SingHealth Duke-NUS Blood Cancer Centre, Singapore; and

7. Genome Institute of Singapore, Singapore

Abstract

Key Points Whole genomic and transcriptomic analyses of MEITL revealed multiple potential therapeutic targets. Synergistic effects of pimozide and romidepsin are shown in a well-characterized MEITL PDX model.

Publisher

American Society of Hematology

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3